"OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients" by Brendan D. Curti

Selected Works of Walter J. Urba, MD, PhD

Follow Contact

Article

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

Cancer Research (2013)

Brendan D. Curti, Providence Portland Medical Center
Magdalena Kovacsovics-Bankowski, Providence Portland Medical Center
Nicholas Morris, Providence Portland Medical Center
Edwin Walker, Providence Portland Medical Center
Lana Chisholm, Providence Portland Medical Center
Kevin Floyd, Providence Portland Medical Center
Joshua Walker, Providence St. Vincent Medical Center
Iliana Gonzalez, Providence Portland Medical Center
Tanisha Meeuwsen, Providence Portland Medical Center
Bernard A. Fox, Providence Portland Medical Center
Tarsem Moudgil, Providence Portland Medical Center
William Miller, University of Edinburgh
Daniel Haley, Providence Regional Medical Center Everett
Todd Coffey, Providence Portland Medical Center
Brenda Fisher, Providence Portland Medical Center
Laurie Delanty-Miller, Providence Portland Medical Center
Nicole Rymarchyk, Providence Portland Medical Center
Tracy Kelly, Providence Portland Medical Center
Todd Crocenzi, Providence Portland Medical Center
Eric Bernstein, Providence Portland Medical Center
Rachel Sanborn, Oregon Health & Science University
Walter J. Urba, Providence Regional Medical Center Everett
Andrew D. Weinberg, Providence Regional Medical Center Everett

Link

Disciplines

Publication Date

December 15, 2013

DOI

10.1158/0008-5472.CAN-12-4174

Citation Information

Brendan D. Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, Edwin Walker, et al.. "OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients" Cancer Research Vol. 73 Iss. 24 (2013) p. 7189 - 7198
Available at: http://works.bepress.com/walter-urba/1/